References in periodicals archive ?
An elaboration will be performed for the operations and services during the presentation provided for undesirable adverse effects when the cardiovascular drugs including Dronedarone, Amiodarone, Sotalol and Flecainide are used.
In July 2011, researchers stopped enrollment into a randomized clinical trial of dronedarone in patients with permanent AF when the data and safety monitoring board detected excessive serious vascular events and deaths in the drug-treated patients.
Although dronedarone should clearly not be used for patients with severe heart failure, the safety of most antiarrhythmic drugs for intermediate-risk patients is uncertain," Torp-Pederson wrote in a commentary in the same journal.
I am excited by the launch of dronedarone, which is a valuable additional choice for the treatment of AF.
I am excited by the launch of dronedarone which is a valuable additional choice for the treatment of AF.
Therapeutic use: Dronedarone (11-13), a new antiarrhythmic agent, is indicated to reduce the risk of cardiovascular hospitalization in patients with paroxysmal or persistent atrial fibrillation or flutter who are in sinus rhythm or who will be cardioverted.
Dronedarone (Multaq, X) is an antiarrhythmic agent that is indicated for patients with atrial fibrillation or atrial flutter.
Failing that, are there examples of the two words A and DRONEDARONE simply appearing together?
A separate dronedarone trial (ANDROMEDA) was stopped early due to excess non-cardiac mortality.
Multaq, dronedarone, class III antiarrhythmic, paroxysmal atrial fibrillation, persistent atrial fibrillation, cardiovascular hospitalizations
Edoxaban dosage was reduced by half if any of the following was present at randomization or during the course of the study: creatinine clearance 30-50 mL/min, body-weight < or = 60 kg, or concomitant verapamil, quinidine or dronedarone (standard dosing was resumed if the concomitant drug was discontinued and no other dose reduction factors were present).
Even dronedarone, the novel iodine-free amiodarone derivative, is now contraindicated in heart failure in light of the disappointing and unexpected results of the ANDROMEDA study (23).